Filing metadata

Accession number
0001415889-24-010677
Form type
Form 3
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Apr 10, 2024
Reporting period
Apr 08, 2024
Description
Initial ownership

Explore SEC Filings Hub